Related Experiment Video
Updated: Aug 18, 2026

Paw-Print Analysis of Contrast-Enhanced Recordings (PrAnCER): A Low-Cost, Open-Access Automated Gait Analysis System for Assessing Motor Deficits
Published on: August 12, 2019
Nocturnal activity with nighttime pergolide in Parkinson disease: a controlled study using actigraphy
Cynthia L Comella1, Mary Morrissey, Kimberly Janko
1Department of Neurologic Sciences, Rush University Medical Center, 1725 W. Harrison, Chicago, IL 60612, USA. ccomella@rush.edu
Abstract:
Pergolide is a dopamine agonist that improves Parkinson disease but is associated with dose-dependent sleepiness. This study evaluates the effect of a nighttime dose of 1 mg of pergolide on actigraphic measures of sleep using a randomized, double-blind, placebo-controlled study design. The pergolide group (n = 10) worsened in actigraphic measures of sleep efficiency and sleep fragmentation vs the placebo group (n = 12). Side effects were more frequent in the pergolide group.
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Management of Insomnia
Parkinson Disease l: Introduction
Parkinson's Disease: Overview
REM Sleep Behavior Disorder
RBD is significantly associated with...

